Andreas Claas
Overview
Explore the profile of Andreas Claas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gossage L, Murtaza M, Slatter A, Lichtenstein C, Warren A, Haynes B, et al.
Genes Chromosomes Cancer
. 2013 Oct;
53(1):38-51.
PMID: 24166983
VHL is mutated in the majority of patients with clear cell renal cell carcinoma (ccRCC), with conflicting clinical relevance. Recent studies have identified recurrent mutations in histone modifying and chromatin...
2.
Schulte T, Ankermann T, Claas A, Engler S
J Pediatr Surg
. 2009 Oct;
44(10):e9-12.
PMID: 19853739
Tracheoesophageal fistulas without atresia of the esophagus are rare abnormalities of the upper gastrointestinal tract with an incidence rate of between 1% and 5%. Even more infrequent are 2 tracheoesophageal...
3.
Praml C, Schulz W, Claas A, Mollenhauer J, Poustka A, Ackermann R, et al.
Cancer Lett
. 2008 Aug;
272(1):160-6.
PMID: 18752886
AFAR genes play a key role in the detoxification of the carcinogen Aflatoxin B(1) (AFB(1)). In the rat, Afar1 induction can prevent AFB(1)-induced liver cancer. It has been proposed that...
4.
Sagulenko E, Savelyeva L, Ehemann V, Sagulenko V, Hofmann W, Arnold K, et al.
Cancer Lett
. 2007 Aug;
257(1):65-72.
PMID: 17686574
Mounting evidence implicates BRCA2 not only in maintenance of genome integrity but also in cell-cycle checkpoints. However, the contribution of BRCA2 in the checkpoints is still far from being understood....
5.
Fries F, Nazarenko I, Hess J, Claas A, Angel P, Zoller M
Int J Cancer
. 2007 Feb;
120(10):2135-47.
PMID: 17278103
The glycosylphosphatidylinositol-anchored molecule C4.4A, which shares structural features with uPAR, is frequently expressed on carcinomas with upregulated expression during tumor progression. Moreover, rare expression on nontransformed epithelial cells is strongly...
6.
Henrich K, Claas A, Praml C, Benner A, Mollenhauer J, Poustka A, et al.
Eur J Cancer
. 2007 Jan;
43(3):607-16.
PMID: 17222547
Deletion of a distal portion of 1p is seen in a wide range of human malignancies, including neuroblastoma. Here, a 1p36.3 commonly deleted region of 216 kb has been defined...
7.
Tarsounas M, Munoz P, Claas A, Smiraldo P, Pittman D, Blasco M, et al.
Cell
. 2004 Apr;
117(3):337-47.
PMID: 15109494
The five RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3) are required in mammalian cells for normal levels of genetic recombination and resistance to DNA-damaging agents. We report here that...
8.
Schwab M, Claas A, Savelyeva L
Cancer Lett
. 2001 Dec;
175(1):1-8.
PMID: 11734330
The identification of the breast cancer susceptibility genes BRCA1 and BRCA2 a few years ago has been greeted with great excitement and has raised hopes that they might illuminate the...